Correction to: Therapeutic novelties in migraine: new drugs, new hope?

Correction to: J Headache Pain (2019) 20:37

https://doi.org/10.1186/s10194-019-0974-3

After publication of the original article [1], the authors have notified us that the row corresponding to the “Alniditan” drug shouldn’t have been included in Table 1. Table 1 should therefore be presented as below:

Table 1.

Overview of ditans in alphabetical order

Drug	Status
Lasmiditan (COL-144)	Phase III clinical trials
LY-334370	Development terminated